141 related articles for article (PubMed ID: 29435163)
1. Aberrant frequency of TNFR2
Zhang T; Jiao J; Jiao X; Zhao L; Tian X; Zhang Q; Ma D; Cui B
Oncotarget; 2018 Jan; 9(4):5073-5083. PubMed ID: 29435163
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.
Kampan NC; Madondo MT; McNally OM; Stephens AN; Quinn MA; Plebanski M
Front Immunol; 2017; 8():1482. PubMed ID: 29163543
[TBL] [Abstract][Full Text] [Related]
3. Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment.
Govindaraj C; Scalzo-Inguanti K; Madondo M; Hallo J; Flanagan K; Quinn M; Plebanski M
Clin Immunol; 2013 Oct; 149(1):97-110. PubMed ID: 23948613
[TBL] [Abstract][Full Text] [Related]
4. Aberrant frequency of TNFR2-expressing CD4+ FoxP3+ regulatory T cells in nasopharyngeal carcinoma patients.
Engku Abd Rahman ENS; Irekeola AA; Shueb RH; Mat Lazim N; Mohamud R; Chen X; Ghazali L; Awang NMSH; Haron A; Chan YY
Cytokine; 2023 Oct; 170():156341. PubMed ID: 37657236
[TBL] [Abstract][Full Text] [Related]
5. Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients.
Govindaraj C; Tan P; Walker P; Wei A; Spencer A; Plebanski M
Clin Cancer Res; 2014 Feb; 20(3):724-35. PubMed ID: 24297862
[TBL] [Abstract][Full Text] [Related]
6. Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis.
Verwoerd A; Hijdra D; Vorselaars AD; Crommelin HA; van Moorsel CH; Grutters JC; Claessen AM
Clin Exp Immunol; 2016 Aug; 185(2):263-70. PubMed ID: 27158798
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis.
Ye LL; Peng WB; Niu YR; Xiang X; Wei XS; Wang ZH; Wang X; Zhang SY; Chen X; Zhou Q
Ann Transl Med; 2020 Dec; 8(24):1647. PubMed ID: 33490159
[TBL] [Abstract][Full Text] [Related]
8. TNF-TNFR2 Signal Plays a Decisive Role in the Activation of CD4
Islam MS; Yang Y; Chen X
Adv Exp Med Biol; 2021; 1278():257-272. PubMed ID: 33523452
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells with CD62L or TNFR2 expression in young type 1 diabetic patients: relation to inflammation, glycemic control and micro-vascular complications.
El-Samahy MH; Adly AA; Ismail EA; Salah NY
J Diabetes Complications; 2015; 29(1):120-6. PubMed ID: 25113439
[TBL] [Abstract][Full Text] [Related]
10. Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis.
Guo G; Morrissey J; McCracken R; Tolley T; Liapis H; Klahr S
Am J Physiol Renal Physiol; 2001 May; 280(5):F777-85. PubMed ID: 11292619
[TBL] [Abstract][Full Text] [Related]
11. The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4
He T; Liu S; Chen S; Ye J; Wu X; Bian Z; Chen X
Front Immunol; 2018; 9():1556. PubMed ID: 30038619
[TBL] [Abstract][Full Text] [Related]
12. TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function.
Nagar M; Jacob-Hirsch J; Vernitsky H; Berkun Y; Ben-Horin S; Amariglio N; Bank I; Kloog Y; Rechavi G; Goldstein I
J Immunol; 2010 Apr; 184(7):3570-81. PubMed ID: 20181891
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis.
Chopra M; Riedel SS; Biehl M; Krieger S; von Krosigk V; Bäuerlein CA; Brede C; Jordan Garrote AL; Kraus S; Schäfer V; Ritz M; Mattenheimer K; Degla A; Mottok A; Einsele H; Wajant H; Beilhack A
Carcinogenesis; 2013 Jun; 34(6):1296-303. PubMed ID: 23385062
[TBL] [Abstract][Full Text] [Related]
14. Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis.
Deckert-Schlüter M; Bluethmann H; Rang A; Hof H; Schlüter D
J Immunol; 1998 Apr; 160(7):3427-36. PubMed ID: 9531303
[TBL] [Abstract][Full Text] [Related]
15. Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8+ T Cells and TNF Receptor Superfamily Member 1a on Non-CD8+ T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection.
Manam S; Thomas JD; Li W; Maladore A; Schripsema JH; Ramsey KH; Murthy AK
J Infect Dis; 2015 Jun; 211(12):2014-22. PubMed ID: 25552370
[TBL] [Abstract][Full Text] [Related]
16. Blockade of TNF-α/TNFR2 signalling suppresses colorectal cancer and enhances the efficacy of anti-PD1 immunotherapy by decreasing CCR8+ T regulatory cells.
Guo Y; Xie F; Liu X; Ke S; Chen J; Zhao Y; Li N; Wang Z; Yi G; Shen Y; Li D; Zhu C; Zhang Z; Zhao G; Lu H; Li B; Zhao W
J Mol Cell Biol; 2023 Nov; ():. PubMed ID: 37935468
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation.
Kondo S; Sauder DN
Eur J Immunol; 1997 Jul; 27(7):1713-8. PubMed ID: 9247582
[TBL] [Abstract][Full Text] [Related]
18. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development.
Arnott CH; Scott KA; Moore RJ; Robinson SC; Thompson RG; Balkwill FR
Oncogene; 2004 Mar; 23(10):1902-10. PubMed ID: 14661063
[TBL] [Abstract][Full Text] [Related]
19. Transmembrane TNF-TNFR2 Impairs Th17 Differentiation by Promoting Il2 Expression.
Miller PG; Bonn MB; McKarns SC
J Immunol; 2015 Sep; 195(6):2633-47. PubMed ID: 26268655
[TBL] [Abstract][Full Text] [Related]
20. TNFR1 and TNFR2, Which Link NF-κB Activation, Drive Lung Cancer Progression, Cell Dedifferentiation, and Metastasis.
Shi G; Hu Y
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
